5(top 1%)
papers
177(top 1%)
citations
3(top 1%)
h-index
5(top 1%)
g-index
5
all documents
184
doc citations
106
citing journals

Top Articles

#TitleJournalYearCitations
1Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803European Journal of Cancer2011101
2Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)Breast Cancer Research and Treatment201159
3D7-07: A phase II NCCTG “Window of Opportunity Front-line” study of the mTOR Inhibitor, CCI-779 (Temsirolimus) given as a single agent in patients with advanced NSCLCJournal of Thoracic Oncology200720
4Systematic education and utilization of volunteer patient advocates for cancer clinical trial information dissemination at NCCTG community sitesJournal of Clinical Oncology20043
5Systematic education and utilization of volunteer patient advocates for cancer clinical trial information dissemination at NCCTG community sitesJournal of Clinical Oncology20041